Premarket Approval (PMA)
Premarket Approval (PMA) is the FDA's most rigorous review pathway for high-risk medical devices, requiring manufacturers to submit clinical evidence proving safety and effectiveness before the device can be marketed. It applies to Class III devices.
What is Premarket Approval (PMA)?
Premarket Approval (PMA) is the most stringent review process the FDA applies to medical devices, reserved for the highest-risk products. To gain approval, a manufacturer must submit substantial clinical evidence demonstrating that the device is both safe and effective for its intended use.
This pathway applies to Class III devices, which generally support or sustain life, are implanted, or pose significant potential risk. Unlike less rigorous routes that rely on showing similarity to an existing product, PMA demands independent proof of the device's performance.
Why does Premarket Approval matter?
Because PMA targets devices where failure could cause serious harm, it serves as a high bar that filters which high-risk products reach the market. The clinical evidence requirement gives clinicians and patients greater assurance about the device's safety profile.
The process is also expensive and time-consuming, which shapes how and when manufacturers bring advanced devices to market. For facilities adopting cutting-edge technology, a device's PMA status signals both its regulatory standing and the depth of evidence behind it.
- what is premarket approval
- pma fda meaning
- premarket approval definition
- pma vs 510k
- pma class iii device
- fda pma pathway